MSD Animal Health, a division of Merck & Co., announced on May 24 the presentation of 19 abstracts at the 14th European Symposium of Porcine Health Management (ESPHM), highlighting new research across the company's broad swine portfolio, including its intradermal vaccine, PORCILIS® Lawsonia ID.